KPC-2-IN-1 is a potent KPC-2 inhibitor (Ki = 0.032 μM) that enhances the activity of cefotaxime in KPC-2-expressing Escherichia coli; it exhibits good tolerability in human HEK-293 cells and can be used in research on Escherichia coli resistance to β-lactam antibiotics.